Ubs Group Ag Codexis, Inc. Transaction History

Ubs Group Ag

  • $527 Billion
  • Q4 2024

A detailed history of Ubs Group Ag transactions in Codexis, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 53,186 shares of CDXS stock, worth $224,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,186
Previous 38,342 38.71%
Holding current value
$224,976
Previous $118,000 114.41%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$2.91 - $5.81 $43,196 - $86,243
14,844 Added 38.71%
53,186 $253,000
Q3 2024

Nov 14, 2024
BUY
$2.62 - $3.71 $43,934 - $62,212
16,769 Added 77.73%
38,342 $118,000
Q2 2024

Aug 13, 2024
SELL
$2.65 - $3.92 $137,156 - $202,887
-51,757 Reduced 70.58%
21,573 $66,000
Q1 2024

May 13, 2024
BUY
$2.59 - $4.65 $8,764 - $15,735
3,384 Added 4.84%
73,330 $255,000
Q4 2023

Feb 09, 2024
BUY
$1.54 - $3.37 $82,571 - $180,692
53,618 Added 328.38%
69,946 $213,000
Q3 2023

Nov 09, 2023
SELL
$1.5 - $3.75 $59,271 - $148,177
-39,514 Reduced 70.76%
16,328 $30,000
Q2 2023

Aug 11, 2023
BUY
$2.21 - $4.43 $40,602 - $81,387
18,372 Added 49.03%
55,842 $156,000
Q1 2023

May 12, 2023
SELL
$3.81 - $6.76 $50,551 - $89,691
-13,268 Reduced 26.15%
37,470 $155,000
Q4 2022

Feb 08, 2023
BUY
$4.26 - $6.84 $162,254 - $260,521
38,088 Added 301.09%
50,738 $236,000
Q3 2022

Nov 10, 2022
BUY
$6.06 - $12.86 $70,805 - $150,256
11,684 Added 1209.52%
12,650 $76,000
Q2 2022

Aug 10, 2022
SELL
$8.35 - $21.89 $551 - $1,444
-66 Reduced 6.4%
966 $10,000
Q1 2022

May 16, 2022
SELL
$16.97 - $31.93 $20,482 - $38,539
-1,207 Reduced 53.91%
1,032 $21,000
Q4 2021

Feb 14, 2022
BUY
$25.61 - $41.78 $29,912 - $48,799
1,168 Added 109.06%
2,239 $70,000
Q3 2021

Nov 15, 2021
SELL
$19.65 - $27.99 $46,374 - $66,056
-2,360 Reduced 68.78%
1,071 $25,000
Q2 2021

Aug 13, 2021
SELL
$17.48 - $25.46 $184,239 - $268,348
-10,540 Reduced 75.44%
3,431 $78,000
Q1 2021

May 12, 2021
BUY
$18.08 - $28.8 $115,892 - $184,608
6,410 Added 84.78%
13,971 $320,000
Q4 2020

Feb 11, 2021
SELL
$11.7 - $23.41 $41,371 - $82,777
-3,536 Reduced 31.86%
7,561 $166,000
Q3 2020

Nov 12, 2020
SELL
$11.21 - $13.82 $183,305 - $225,984
-16,352 Reduced 59.57%
11,097 $131,000
Q2 2020

Jul 31, 2020
SELL
$9.8 - $12.77 $81,810 - $106,603
-8,348 Reduced 23.32%
27,449 $313,000
Q1 2020

May 01, 2020
SELL
$8.78 - $18.6 $534,605 - $1.13 Million
-60,889 Reduced 62.98%
35,797 $400,000
Q4 2019

Feb 14, 2020
BUY
$13.12 - $17.06 $393,101 - $511,151
29,962 Added 44.9%
96,686 $1.55 Million
Q3 2019

Nov 14, 2019
BUY
$12.75 - $19.01 $364,331 - $543,210
28,575 Added 74.9%
66,724 $915,000
Q2 2019

Aug 14, 2019
BUY
$17.0 - $21.88 $134,623 - $173,267
7,919 Added 26.2%
38,149 $703,000
Q1 2019

May 14, 2019
SELL
$15.53 - $22.15 $333,258 - $475,316
-21,459 Reduced 41.52%
30,230 $621,000
Q4 2018

Feb 14, 2019
BUY
$14.06 - $22.57 $77,470 - $124,360
5,510 Added 11.93%
51,689 $863,000
Q3 2018

Nov 14, 2018
BUY
$13.35 - $19.1 $195,550 - $279,776
14,648 Added 46.46%
46,179 $792,000
Q2 2018

Aug 14, 2018
SELL
$10.35 - $16.45 $31,702 - $50,386
-3,063 Reduced 8.85%
31,531 $454,000
Q1 2018

May 15, 2018
BUY
$8.0 - $12.8 $29,744 - $47,590
3,718 Added 12.04%
34,594 $381,000
Q4 2017

Feb 14, 2018
BUY
$5.85 - $8.4 $27,799 - $39,916
4,752 Added 18.19%
30,876 $258,000
Q3 2017

Nov 14, 2017
SELL
$4.9 - $6.65 $21,016 - $28,521
-4,289 Reduced 14.1%
26,124 $174,000
Q2 2017

Aug 14, 2017
BUY
N/A
28,553 Added 1535.11%
30,413 $166,000
Q1 2017

Nov 14, 2017
BUY
N/A
1,860
1,860 $9,000

Others Institutions Holding CDXS

# of Institutions
144
Shares Held
60.6M
Call Options Held
68.5K
Put Options Held
20.1K
View Full List

About CODEXIS, INC.

CDXS Quotes by TradingView
  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $277M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email